Rejuvenation Nutraceuticals
General Healthspan, Cellular Aging
Pre-clinical / Early ClinicalActive
Key Facts
Indication
General Healthspan, Cellular Aging
Phase
Pre-clinical / Early Clinical
Status
Active
Company
About clock.bio
clock.bio is pioneering the field of rejuvenation biology, aiming to extend human healthspan by reversing cellular aging rather than just slowing it down. The company's integrated platform, comprising the geneAge Atlas, imAge AI model, and clinAge clinical trial engine, systematically maps genetic drivers of aging and validates interventions. Starting with topical and nutraceutical applications for rapid human validation, clock.bio is building a scientific foundation for future systemic therapies targeting the root causes of age-related decline.
View full company profile